AstraZeneca (NYSE: AZN) announced that the US Food and Drug Administration (FDA) has approved TAGRISSO (osimertinib) (AZD9291) 80mg once-daily tablets ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE